The company is asking the court to continue business practices and a potential sale of assets during the bankruptcy process, according to SEC filings. Shares of InVivo fell 48% amid news of the filing, according to Market Watch.
InVivo Therapeutics’ implants aim to help patients with acute thoracic spinal cord injuries, according to its website.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
